Announce Date | 02/25/2025 |
EPS Normalized Actual | $1.82 (Beat by $0.13) |
EPS GAAP Actual | $1.82 (Beat by $0.13) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 05/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.635 |
EPS GAAP Estimate | $1.635 |
Revenue Estimate | $1.268851B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2027 | 7.46 | 17.02 | 7.2582 | 7.60555 | 1 |
Oct 2026 | 9.74 | 13.03 | 8.39 | 11.09 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 0.97 | 0.97 | 0B | -INF% | 0M |
FQ4 2024 (Oct 2024) | -0.42 | -0.42 | 0.008B | -16287.5% | 8M |
FQ3 2024 (Jul 2024) | 2.24 | 2.24 | 1.217B | -13.56% | 1217M |
FQ2 2024 (Apr 2024) | 0.72 | 0.72 | 1.216B | 100% | 1216M |
FQ1 2024 (Jan 2024) | 0.98 | 0.98 | 1.259B | -9.69% | 1259M |
FQ4 2023 (Oct 2023) | 1.28 | 1.28 | 1.311B | -10.07% | 1311M |
FQ1 2001 (Jan 2001) | 0 | 0 | 0B | NAN% | 0M |
FQ4 2001 (Oct 2001) | 1.66 | 1.66 | 0.02B | 100% | 20M |
FQ4 Announce Date
05/01/2025 (Pre-Market)
Consensus EPS Estimates
1.635
Consensus Revenue Estimates
1.268851B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.34084 | -- | 2.33324 | 2.36031 | 5 |
FQ3 2027 (Jul 2027) | 2.18052 | -- | 2.17344 | 2.19865 | 5 |
FQ2 2027 (Apr 2027) | 2.03439 | -- | 2.00909 | 2.04203 | 4 |
FQ1 2027 (Jan 2027) | 2.12205 | -- | 2.09566 | 2.13002 | 2 |
FQ4 2026 (Oct 2026) | 3.21 | -- | 3.18365 | 3.24723 | 5 |
FQ3 2026 (Jul 2026) | 2.79 | -- | 2.7671 | 2.82236 | 3 |
FQ2 2026 (Apr 2026) | 2.45 | -- | 2.42989 | 2.47842 | 5 |
FQ1 2026 (Jan 2026) | 2.36 | 58.9 | 2.32943 | 2.39112 | 2 |
FQ4 2025 (Oct 2025) | 2.04286 | 120.56 | 2.02609 | 2.06656 | 6 |
FQ3 2025 (Jul 2025) | 1.83714 | -21.93 | 1.82206 | 1.85845 | 4 |
FQ2 2025 (May 2025) | 1.635 | 55.96 | 1.61042 | 1.6548 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 1.55B | -- | 1.54B | 1.56B | 5 |
FQ3 2027 (Jul 2027) | 1.48B | -- | 1.48B | 1.49B | 5 |
FQ2 2027 (Apr 2027) | 1.45B | -- | 1.43B | 1.45B | 2 |
FQ1 2027 (Jan 2027) | 1.45B | -- | 1.44B | 1.46B | 2 |
FQ4 2026 (Oct 2026) | 1.8B | -- | 1.79B | 1.81B | 6 |
FQ3 2026 (Jul 2026) | 1.67B | -- | 1.66B | 1.69B | 3 |
FQ2 2026 (Apr 2026) | 1.57B | -- | 1.56B | 1.59B | 3 |
FQ1 2026 (Jan 2026) | 1.5B | -- | 1.48B | 1.51B | 3 |
FQ4 2025 (Oct 2025) | 1.42B | 99.44 | 1.41B | 1.43B | 2 |
FQ3 2025 (Jul 2025) | 1.32B | 7.66 | 1.31B | 1.33B | 2 |
FQ2 2025 (May 2025) | 1.27B | 4.17 | 1.25B | 1.28B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 0.97 | 0.97 | 100% | |
FQ4 2024 (Oct 2024) | -0.42 | -0.42 | 100% | |
FQ3 2024 (Jul 2024) | 2.24 | 2.24 | 100% | |
FQ2 2024 (Apr 2024) | 0.72 | 0.72 | 100% | |
FQ1 2024 (Jan 2024) | 0.98 | 0.98 | 100% | |
FQ4 2023 (Oct 2023) | 1.28 | 1.28 | 100% | |
FQ1 2001 (Jan 2001) | 0 | 0 | NAN% | |
FQ4 2001 (Oct 2001) | 1.66 | 1.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $0B | $0M | NAN% |
FQ4 2024 (Oct 2024) | $0B | $0.01B | $8M | 100% |
FQ3 2024 (Jul 2024) | $0B | $1.22B | $1217M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.22B | $1216M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.26B | $1259M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.31B | $1311M | 100% |
FQ1 2001 (Jan 2001) | $0B | $0B | $0M | NAN% |
FQ4 2001 (Oct 2001) | $0B | $0.02B | $20M | 100% |